Skip to search formSkip to main contentSkip to account menu

Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

Known as: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, DTaP, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine 
A vaccine containing detoxified tetanus toxoid, detoxified diphtheria toxoid and acellular pertussis antigens, adsorbed on aluminum phosphate, with… 
National Institutes of Health

Related topics

Related topics

7 relations
Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis VaccinePolyvalent VaccineTetanus and diphtheria toxoid adsorbed for adult usediphtheria, tetanus toxoids and acellular pertussis vaccine

Broader (2)

Diphtheria-Tetanus-(whole-cell) Pertussis VaccineDiphtheria-Tetanus-Pertussis Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium
Methods and Objectives. To estimate infant vaccination coverage in the French-speaking region of Belgium (Wallonia) and in the… 
Review
2013
Review
2013
DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®)
Hexaxim® (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing… 
Highly Cited
2006
Highly Cited
2006
Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of…
Review
2004
Review
2004
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Highly Cited
2001
Highly Cited
2001
Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural…
ABSTRACT The aim of this study was to compare pertussis-specific humoral and cellular immunity in children 5 years after a… 
2001
2001
Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered…
We compared the antibody response to Haemophilus influenzae type b capsular polysaccharide (PRP) after 1, 2, or 3 doses of a… 
Highly Cited
1999
Highly Cited
1999
The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
The significance of reduced antibody responses to the Haemophilus influenzae type b (Hib) component of acellular pertussis… 
1999
1999
Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to…
Highly Cited
1998
Highly Cited
1998
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.
Highly Cited
1997
Highly Cited
1997
Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib…
We compared antibody levels following separate but simultaneous administration of diphtheria and tetanus toxoids with acellular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)